Bio-Techne Corp TECH
72.61
0.04
0.06%
as of 25 Sep
- Market cap
- $11.4B
- P/E
- 62.1×
Follow TECH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
3.80% | 3.97% | 5.34% | 9.03% | |
| 2.96% | 3.12% | 4.22% | 7.07% | ||
ROIC |
3.24% | 3.48% | 4.63% | 7.70% | |
Return on Tangible Assets |
11.06% | 11.09% | 14.27% | 22.38% | |
Average Days of Receivables |
55.17 | 55.43 | 64.68 | 65.06 | |
Free Cash Flow per Share |
1.44 | 1.43 | 1.72 | 1.69 | |
Free Cash Flow |
224.06 | 223.02 | 269.60 | 263.22 | |
Capital Expenditures |
(27.20) | (26.30) | (25.26) | (28.85) | |
Piotroski F-Score |
4.00 | 6.00 | 6.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
10.42% | 10.20% | 11.82% | 11.35% | |
Accounts Receivable Turnover |
5.97 | 6.04 | 5.36 | 5.74 | |
Accounts Payable Turnover |
13.66 | 14.24 | 15.39 | 16.00 | |
Inventory Turnover |
2.17 | 2.15 | 2.16 | 2.16 | |
Average Days of Payables |
26.12 | 22.68 | 20.21 | 23.43 | |
Days of Inventory on Hand |
176.01 | 177.35 | 173.05 | 171.76 | |
Tax Rate |
(0.27) | (0.29) | (0.26) | (0.24) | |
Research and Development Expense of Revenue |
8.21% | 8.06% | 8.00% | 7.80% | |
Selling, General and Administrative Expense of Revenue |
48.13% | 47.53% | 44.26% | 37.23% | |
Share Based Compensation of Revenue |
3.48% | 3.42% | 3.36% | 3.40% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
3.22 | 3.07 | 2.69 | 1.61 | |
Depreciation/Fixed assets |
0.44 | 0.44 | 0.43 | 0.42 | |
Capex/Depreciation |
(0.26) | (0.25) | (0.25) | (0.30) | |
Revenue per Share |
7.83 | 7.80 | 7.75 | 7.79 | |
Operating CF per Share |
1.62 | 1.60 | 1.89 | 1.87 | |
Capex per Share |
(0.17) | (0.17) | (0.16) | (0.18) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
6.41% | 6.67% | 9.05% | 14.97% |
Columns are period end dates